Catalyst Wire Dossier Catalyst Wire Dossier

TAXUS Petal Bifurcation Coronary Stent System

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAXUS Petal Bifurcation Coronary Stent System, covering 2015-03-26 to 2015-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System [Phase 1]

See pricing